Drug-Resistant Malaria - libdoc.who.int - World Health Organization

Table 7.
Specific Actions for the Control of Transmission and Prevalence of Drug-Resistant P.falciparum
(Continued)
Areas where the existence of
resistant P.falciparum is well
established and widespread
Ar~as with limited foci of resistant
P.falciparllm already established
Areas where resIstant P.falciparum
infectIons have not been recognized
7. Monitor the extent and negree
of resistance by annual
in vitro/in vIvo studies in
fixed indicator areas and on an
ad hoc sampling basis.
8. Assess the sensitivity of local
P.falciparlm to current antimalarial
drugs to establish a
baseline.
9. 'Escablish an information
system to monit~r the clinical
respon.se to alternative
antimalarial drugs in use .•
7. Monitor the susceptibility of P.falciparum
to drugs in selected
indicator areas, annually. by in vitro/
in vivo techniques within the already
established foci and also on an ad hoc
sampling basis.
8. Assess the sensitivity of local
P.falciparum to current antimalarial
drugs to establ ish a baseline.
9. Establish an information system to
monitor the clinical responlleto antimalarial
drugs in use throughout the
public and private medical 5ect.ors.
This information can be used to
determine when and where to carry ~ut
1111 ·hoc studies.
7. Introduce and enforce a rational
use of antimalarial drugs throughout
the country.
8. Intensify appropriate anti-vector
measures in areas where imported
cases of resistant P.falciparum
malaria have been detected and where
the receptivity is sufficiently high
to support local transmission.
(')
~
!
t'"
......
Q\
IN